Examining the patient and caregiver experience with diazepam nasal spray for seizure clusters: Results from an exit survey of a phase 3, open-label, repeat-dose safety study.

Saved in:
Bibliographic Details
Title: Examining the patient and caregiver experience with diazepam nasal spray for seizure clusters: Results from an exit survey of a phase 3, open-label, repeat-dose safety study.
Authors: Penovich P; Minnesota Epilepsy Group, 225 Smith Ave N, Suite 201, St. Paul, MN 55102, United States. Electronic address: ppenovich@mnepilepsy.net., Wheless JW; Le Bonheur Children's Hospital, University of Tennessee Health Science Center, Pediatric Neurology, 49 N Dunlap Ave, 3rd Floor - FOB, Memphis, TN 38105, United States., Hogan RE; Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110, United States., Guerra C; Neurelis, Inc., 3430 Carmel Mountain Road, Suite 300, San Diego, CA 92121, United States., Cook DF; Neurelis, Inc., 3430 Carmel Mountain Road, Suite 300, San Diego, CA 92121, United States., Carrazana E; Neurelis, Inc., 3430 Carmel Mountain Road, Suite 300, San Diego, CA 92121, United States., Rabinowicz AL; Neurelis, Inc., 3430 Carmel Mountain Road, Suite 300, San Diego, CA 92121, United States.
Source: Epilepsy & behavior : E&B [Epilepsy Behav] 2021 Aug; Vol. 121 (Pt A), pp. 108013. Date of Electronic Publication: 2021 May 19.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Academic Press Country of Publication: United States NLM ID: 100892858 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-5069 (Electronic) Linking ISSN: 15255050 NLM ISO Abbreviation: Epilepsy Behav Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1525-5069
DOI:10.1016/j.yebeh.2021.108013